Authors: Slamon, DJ Leyland-Jones, B Shak, S Fuchs, H Paton, V Bajamonde, A Fleming, T Eiermann, W Wolter, J Pegram, M Baselga, J Norton, L

Citation: Dj. Slamon et al., Use of chemotherapy plus a monoclonal antibody against HER2 for metastaticbreast cancer that overexpresses HER2., N ENG J MED, 344(11), 2001, pp. 783-792

Authors: Elhilali, MM Gleave, M Fradet, Y Davis, I Venner, P Saad, F Klotz, L Moore, R Ernst, S Paton, V

Citation: Mm. Elhilali et al., Placebo-associated remissions in a multicentre, randomized, double-blind trial of interferon gamma-1b for the treatment of metastatic renal cell carcinoma, BJU INT, 86(6), 2000, pp. 613-618

Authors: Brooks, JD Paton, V

Citation: Jd. Brooks et V. Paton, Potent induction of carcinogen defence enzymes with sulforaphane, a putative prostate cancer chemopreventive agent, PROSTATE C, 2, 1999, pp. S8-S8

Authors: Cobleigh, MA Vogel, CL Tripathy, D Robert, NJ Scholl, S Fehrenbacher, L Wolter, JM Paton, V Shak, S Lieberman, G Slamon, DJ

Citation: Ma. Cobleigh et al., Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease, J CL ONCOL, 17(9), 1999, pp. 2639-2648

Authors: Paton, V

Citation: V. Paton, Furniture, industry and culture in Spain, CUADERNOS H, (591), 1999, pp. 49-57